These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11828860)

  • 1. Continuation of postpartum antiretroviral therapy in a cohort of women infected with human immunodeficiency virus.
    Tedaldi E; Willard S; Gilmore J; Holdsworth C; Dix-Lassiter S; Axelrod P
    J Assoc Nurses AIDS Care; 2002; 13(1):60-5. PubMed ID: 11828860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with HIV-infected patients' recognition and use of HIV medications.
    Jeffe DB; Meredith KL; Mundy LM; Fraser VJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):350-60. PubMed ID: 9833743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis.
    Laine C; Newschaffer CJ; Zhang D; Cosler L; Hauck WW; Turner BJ
    Obstet Gynecol; 2000 Feb; 95(2):167-73. PubMed ID: 10674574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV control in postpartum mothers: a turbulent time.
    Loftus H; Burnett A; Naylor S; Bates S; Greig J
    Int J STD AIDS; 2016 Jul; 27(8):680-3. PubMed ID: 26384944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevirapine in HIV maintenance therapy - can "old drugs" survive in current HIV management?
    Notter J; Bregenzer A; Vernazza P; Kahlert CR
    Swiss Med Wkly; 2019 Apr; 149():w20053. PubMed ID: 31017649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicultural and psychosocial aspects of HIV treatment failure.
    Howard K
    Focus; 2001 Jun; 16(7):1-4. PubMed ID: 11548662
    [No Abstract]   [Full Text] [Related]  

  • 12. HAART adherence in culturally diverse patients with HIV/AIDS: a study of male patients from a Veteran's Administration Hospital in northern California.
    Kemppainen JK; Levine RE; Mistal M; Schmidgall D
    AIDS Patient Care STDS; 2001 Mar; 15(3):117-27. PubMed ID: 11313024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy.
    Gupta A; Gupte N; Bhosale R; Kakrani A; Kulkarni V; Nayak U; Thakar M; Sastry J; Bollinger RC;
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):338-42. PubMed ID: 17846559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3.
    Currier JS; Britto P; Hoffman RM; Brummel S; Masheto G; Joao E; Santos B; Aurpibul L; Losso M; Pierre MF; Weinberg A; Gnanashanmugam D; Chakhtoura N; Klingman K; Browning R; Coletti A; Mofenson L; Shapiro D; Pilotto J;
    PLoS One; 2017; 12(5):e0176009. PubMed ID: 28489856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of nevirapine in HIV-infected pregnant women initiating antiretroviral therapy at higher CD4 counts: a systematic review and meta-analysis.
    Bera E; Mia R
    S Afr Med J; 2012 Oct; 102(11 Pt 1):855-9. PubMed ID: 23116743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist care.
    Gardner LI; Holmberg SD; Moore J; Arnsten JH; Mayer KH; Rompalo A; Schuman P; Smith DK;
    J Acquir Immune Defic Syndr; 2002 Jan; 29(1):69-75. PubMed ID: 11782593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)].
    ;
    Enferm Infecc Microbiol Clin; 2007 Jan; 25(1):32-53. PubMed ID: 17261244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.
    Kesho Bora Study Group
    Clin Infect Dis; 2012 Aug; 55(3):449-60. PubMed ID: 22573845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.